发明申请
US20110033459A1 COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR
有权
作为平板ADP受体抑制剂的化合物治疗的组合治疗
- 专利标题： COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR
- 专利标题（中）： 作为平板ADP受体抑制剂的化合物治疗的组合治疗
-
申请号： US12908837申请日： 2010-10-20
-
公开(公告)号： US20110033459A1公开(公告)日： 2011-02-10
- 发明人: Pamela B. Conley , Patrick Andre , Uma Sinha
- 申请人： Pamela B. Conley , Patrick Andre , Uma Sinha
- 专利权人： Portola Pharmaceuticals, Inc.
- 当前专利权人： Portola Pharmaceuticals, Inc.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K31/517 ; A61K31/5377 ; A61K31/496 ; A61K31/397 ; A61K38/10 ; A61K31/727 ; A61K31/702 ; A61P7/02
摘要：
The present invention is directed to pharmaceutical compositions and methods of using combination therapies containing [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea, or a pharmaceutically acceptable salt thereof, for the treatment of thrombosis diseases.